COSMIN database

Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer

Authors:
Straatman, J., Joosten, P. J., Terwee, C. B., Cuesta, M. A., Jansma, E. P., and van der Peet, D. L.
Abstract:
Esophageal cancer is currently the eighth most common cancer worldwide. Improvements in operative techniques and neoadjuvant therapies have led to improved outcomes. Resection of the esophagus carries a high risk of severe complications and has a negative impact on health-related quality of life (QOL). The aim of this study was to assess which patient-reported outcome measures (PROMs) are used to measure QOL after esophagectomy for cancer. A comprehensive search of original articles was conducted investigating QOL after surgery for esophageal carcinoma. Two authors independently selected relevant articles, conducted clinical appraisal, and extracted data (PJ and JS). Out of 5893 articles, 58 studies were included, consisting of 41 prospective and 17 retrospective cohort studies, including a total of 6964 patients. These studies included 11 different PROMs. The existing PROMs could be divided into generic, symptom-specific, and disease-specific questionnaires. The European Organisation for Research and Treatment of Cancer (EORTC) QOL Questionnaire Core 30 (QLQ C-30) along with the EORTC QLQ-OESophagus module OES18 was the most widely used; in 42 and 32 studies, respectively. The EORTC and the Functional Assessment of Cancer Therapy (FACT) questionnaires use an oncological module and an organ-specific module. One validation study was available, which compared the FACT and EORTC, showing moderate to poor correlation between the questionnaires. A great variety of PROMs are being used in the measurement of QOL after surgery for esophageal cancer. A questionnaire with a general module along with a disease-specific module for assessment of QOL of different treatment modalities seem to be the most desirable, such as the EORTC and the FACT with their specific modules (EORTC QLQ-OES18 and FACT-E). Both are developed in different treatment modalities, such as in surgical patients. With regard to reproducibility of current results, the EORTC is recommended.
DOI:
10.1111/dote.12405
URL:
https://academic.oup.com/dote/article-abstract/29/7/760/2756833?redirectedFrom=fulltext
Journal:
Dis Esophagus
issn:
1120-8694
Publication year:
2016
pages:
760-772
Overall quality of life:
Overall quality of life
Age:
Adults (18-65)
Disease:
Neoplasms and related symptoms
PRO / non-PRO:
Patient Reported Outcome
Type of measurement instrument:
1 - Questionnaires
Instrument:
DAUGS20 - Dysfunction After Upper Gastrointestinal Surgery scoring system
EORTC QLQ-C30 - European Organization for Research and Treatment of Cancer Quality of Life Questionnaires Core-30 item (ALSO shortened version)   [see: ZUYD (NL)]
EORTC QLQ-OES18 -EORTC quality of life in patients with oesophageal cancer 18 items
EORTC QLQ-OES24 - EORTC questionnaire for patients with oesophageal cancer 24 items
FACT-E - Functional Assessment of Cancer Therapy-Esophageal cancer
FACT-G - Functional Assessment of Cancer Therapy-General
POMS - Profile of Mood States
RSCL - Rotterdam Symptom Checklist   [see: ZUYD (NL)]
SF-20 - MOS short-form general health survey 20 item
SF-36 - 36-item Short Form Health Survey   [see: proqolid, ZUYD (NL)]
VAS - Visual Analogue Scale   [see: ZUYD (NL)]